Clinical Trial Update: Interleukin-2 in Treating Patients With Mycosis Fungoides [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating interleukin-2 in patients with mycosis fungoides; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: University of Washington | Conditions: Lymphoma | Phase 1 | Status: COMPLETED